Trade

Lupin share price

Moderate risk
  • 20%Low risk
  • 20%Moderate risk
  • 20%Balanced risk
  • 20%High risk
  • 20%Extreme risk
  • ₹2,254.55(-0.99%)
    June 17, 2026 13:21:42 PM IST
    • NSE
    • BSE
  • Vol : 174.86 K (NSE + BSE)
    Last 20 day avg : 1.03 M

Lupin is trading -0.99% lower at Rs 2,254.55 as compared to its last closing price. Lupin has been trading in the price range of 2,283.60 & 2,253.90. Lupin has given 7.98% in this year & 0.60% in the last 5 days. Lupin has TTM P/E ratio 18.66 as compared to the sector P/E of 26.87.There are 36 analysts who have initiated coverage on Lupin. There are 6 analysts who have given it a strong buy rating & 10 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 1,460.34 Crores in its last quarter.Listed peers of Lupin include Torrent Pharmaceuticals (-0.53%), Dr Reddy's Laboratories (-0.87%), Cipla (-1.97%).The Mutual Fund holding in Lupin was at 16.93% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Lupin was at 21.70% in 31 Mar 2026. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 17, 2026, 07:56 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.52
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.29
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.79
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    4.63
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    18.38
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.14
    Indicates undervaluation
Price range
Day Range
Lowest
2,253.90
Highest
2,283.60
52 week range
Lowest
1,838.65
Highest
2,492.00
Lupin News
Lupin Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Neutral
4,440.80-0.531,50,290.8167.3217.10.8317.62
Dr Reddy's Laboratories
Moderately Bearish
1,266.00-0.871,05,596.4818.633.140.632.34
Cipla
Neutral
1,345.75-1.971,08,715.7922.953.870.870.81
Sun Pharmaceutical Industries
Bullish
1,811.100.584,34,521.2536.245.770.920.50
Divi's Laboratories
Bullish
6,658.60-0.821,76,353.8078.6111.520.460.01
Mutual Fund Ownership
View all
HDFC Hybrid Debt Fund Growth
4/5
  • Amount Invested (Cr.) 14.23
  • % of AUM 0.42
Lupin Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-07Audited Results & Final Dividend
2026-02-12Quarterly Results
2025-11-06Quarterly Results & Others
2025-08-05Quarterly Results & Others
2025-05-14Audited Results & Final Dividend
About the company Lupin
  • IndustryBiotechnology & Drugs
  • ISININE326A01037
  • BSE Code500257
  • NSE CodeLUPIN
Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. It operates in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti-Inflammatory Drug therapy segments and operates in the Anti-TB and Cephalosporins segments. Its generic formulations include Filgrastim, Peg filgrastim, Etanercept and Albuterol. Its diabetes brands include Gibtulio, Ajaduo, Gibtulio Met, ONDERO and ONDERO MET. Its other brands include AntaGolin, RyChol and others. Its Huminsulin range of products includes Insulin Human.
  • Management Info
  • Vinita GuptaChief Executive Officer, Executive Director
  • Ramesh SwaminathanExecutive Director, Global Chief Financial Officer, Chief Risk Officer and Head of API Plus SBU
  • Fabrice EgrosPresident - Corporate Development
  • Spiro GavarisPresident - US Generics
  • Claus JepsenPresident - Global Specialty
  • Cyrus KarkariaPresident - Biotech Business
  • Yashwant MahadikPresident - Global Human Resources
  • Sofia MumtazPresident - Legal and Compliance, Canada, ANZ and NEA Business
  • Rajeev SibalPresident - India Region Formulations
  • Abdelaziz ToumiChief Executive Officer of Lupin Manufacturing Solutions Limited
Lupin Share Price FAQs

Lupin is trading at 2254.55 as on Wed Jun 17 2026 07:51:42. This is -0.99% lower as compared to its previous closing price of 2277.00.

The market capitalization of Lupin is 103398.69 Cr as on Wed Jun 17 2026 07:51:42.

The average broker rating on Lupin is Hold. The breakup of analyst rating is given below -

  • 6 analysts have given a strong buy rating
  • 10 analysts have given a buy rating
  • 13 analysts have given a hold rating
  • 4 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Lupin is 2492.00 whereas the 52 wk low is 1838.65

Lupin can be analyzed on the following key metrics -

  • TTM P/E: 18.66
  • Sector P/E: 26.87
  • Dividend Yield: 0.79%
  • D/E ratio: 0.29

Lupin reported a net profit of 5332.84 Cr in 2026.

The Mutual Fund Shareholding was 16.93% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Lupin QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Lupin share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.